Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-04

Clinical Trial Update: A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab

View source ↗

Summary

The study examined whether interleukin-7 receptor gene polymorphisms influence Crohn's disease risk and the efficacy of infliximab; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Crohn Disease (CD) | Status: COMPLETED